Medical technologies under development at startups, August 2015

by PatrickDriscoll 3 min read

Below is a list of the technologies under development at medical technology startups identified in August 2015 and added to the Medtech Startup Database.

Non-hormonal, non-invasive treatment for vaginal dryness and atrophy.
Vascular access technology for hemodialysis and oncology.
Stents for peripheral vascular disease.
Combined ultrasound guidance and interventional access probe.
Transendoscopic and laparoscopic instrumentation.
Device for real-time monitoring of blood loss.
Hand-held blood velocity, blood oxygen and heart rate monitor
Endovascular navigation.

For a historical listing of medical technologies at startups since 2008, see link.

PatrickDriscoll (Website)

contributor

I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.